       Document 0403
 DOCN  M9630403
 TI    Gastrointestinal tract cancer in association with hepatitis and HIV
       infection.
 DT    9603
 AU    Fahal AH; el Razig SA; Suliman SH; Ibrahim SZ; Tigani AE; Department of
       Surgery, Faculty of Medicine, University of; Khartoum, Sudan.
 SO    East Afr Med J. 1995 Jul;72(7):424-6. Unique Identifier : AIDSLINE
       MED/96060401
 AB    One hundred and fifty patients with histologically proven
       gastrointestinal tract (GIT) cancer, 150 patients with a variety of
       other malignancies and 150 normal subjects were screened for human
       immunodeficiency virus (HIV) and hepatitis B sero-markers. Only one
       patient with nasopharyngeal carcinoma proved to be HIV seropositive.
       Hepatitis B surface antigen (HBsAg) was detected in 18% (n = 26) of the
       GIT cancer patients, in 16% (n = 24) of the other cancers group and in
       12% (n = 20) of the control. There was no significant difference between
       the three groups (P > 0.1). The HBsAg was detected mainly in patients
       with primary hepatocellular (25%), gastric (12%), rectal (10%) and
       colonic carcinoma (8%). Hepatitis B core antibody (HBc AB) was detected
       in 12% of the GIT cancer patients, in 11% of the other cancers patients
       and in 13% of the control. In this study, there was no association
       between HIV, hepatitis B infections and GIT cancer.
 DE    Adolescence  Adult  Aged  Aged, 80 and over  Case-Control Studies  Child
       Female  Gastrointestinal Neoplasms/*COMPLICATIONS  Hepatitis
       B/*COMPLICATIONS  Human  HIV Infections/*COMPLICATIONS  Male  Mass
       Screening  Middle Age  Prospective Studies  Risk Factors
       Seroepidemiologic Methods  Sudan/EPIDEMIOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

